CXCL9 and neoplasm: M1-type TAMs secrete factors that exert anti-tumor effects: IL-12, TNF-α, and IL-1β activate cytotoxic T cells and NK cells, and CXCL9 recruits Th1 cells and cytotoxic T cells to the TME, enhancing anti-tumor immunity.